GlassScriptPhysician profile
Gerardo Sotomayor
NPI 1265533830
$408.43
in general payments reported to CMS, 2019-2025
10 companies · $46.90 in 2025
The $46.90 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.81 · 2020: $82.53 · 2021: $18.09 · 2022: $87.50 · 2023: $108 · 2024: $51.54 · 2025: $46.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $180.23 | 2019-2024 | |
| Hologic Sales and Service, LLC | $72.49 | 2020-2025 | Aptima |
| Baxter Healthcare | $27.78 | 2023 | Tisseel |
| Astellas Pharma US INC | $25.80 | 2024 | Veozah |
| Coopersurgical, INC. | $25.75 | 2020-2023 | Mara Console |
| Abbvie INC. | $25.60 | 2022 | |
| Ibsa Pharma INC. | $18.32 | 2023 | Tirosint, Licart |
| Millicent US INC | $18.09 | 2021 | |
| Amgen INC. | $14.37 | 2025 | Prolia, Evenity |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerardo Sotomayor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.